Driven by Discovery.
Trusted by Clinicians.
Built on Science.
Redefining the Standard of Care in Stealth Pathogen Diagnosis
Treat with Confidence.
Bartonella, Babesia, Borrelia, stealth pathogens known to evade immune detection, suppress antibody responses, and persist in tissues, often go undetected by conventional diagnostics. Millions of patients remain misdiagnosed or undiagnosed as a result.
Galaxy Diagnostics was built to solve this problem.
We combine direct and indirect detection methods, backed by peer- reviewed science, to help providers identify elusive infections and take informed clinical action.
The Hidden Impact of Stealth Pathogens
14%
Only 14% of Lyme patients present with a bullseye rash1
65%
65% of patients with schizophrenia in one study tested positive for Bartonella2 (Lashnits et al., 2021)
25x
Babesiosis may be underreported by a factor of 25. Estimated 46,000 U.S. cases vs. 1,834 reported by CDC3
(60 Degrees Pharma Survey, 2025)
The Problem: A confusing and incomplete testing landscape.
Today’s diagnostic options are expanding, but not all are equal. Providers face a mix of direct and indirect tests with poor sensitivity and lab-developed options with unclear results and limited transparency. Many return data without clinical context, leaving providers uncertain about what’s actionable.
The Result? Diagnostic guesswork that delays treatment and undermines confidence.
Why Testing Falls Short
- Antibodies can take weeks to develop, missing the critical treatment window
- Serology detects exposure, not active infection
- Stealth pathogens like Bartonella, Babesia, and Borrelia evade immune detection
- Lab-developed tests vary widely in quality design, interpretation, and reproducibility
“There is no kinder form of therapy than an accurate diagnosis.”
—Dr. Ed Breitschwerdt
“Galaxy Diagnostics is the single best test you can order to manage stealth infections. When logic demands an answer, this is the tool.”
—Dr. Jay Stevens, Carolina Family Practice and Sports Medicine
Galaxy’s Approach: Science in Service of Clinical Decisions
We combine direct and indirect detection in a rigorously validated testing platform:
- Digital PCR for up to 10x more sensitivity than standard PCR
- Urine antigen testing detects early and ongoing infection in chronic cases using antigen capture
- Bartonella IFA Panel covering 4 clinically relevant species, including B. koehlerae
- All backed by 450+ peer-reviewed studies
“Galaxy provided the answer when other tests fell short.”
—Dr. Shannon Smith, Turnpaugh Health & Wellness
Where Scientific Rigor Meets Clinical Relevance
Our educational content goes beyond our own findings, highlighting the latest research, clinical trends, and expert insights in the evolving world of complex pathogen detection. We stay at the forefront of the science to help providers make sense of what’s emerging, what’s credible, and what it means for patient care.
Trusted by Providers
Leading functional and
integrative providers rely on our tests
Backed by Science
Peer-reviewed science and academic partnerships validate our approach
Actionable Results
We deliver actionable insights and support so you can treat with confidence
Transparent Methods
Published peer-reviewed publications and responsive support
Trusted by Healthcare Providers Nationwide
Start Testing. Stay Supported.
Register Your Practice
A Galaxy specialist will then contact you to assist based on your workflow.
Order Testing Supplies
Order testing supplies for in clinic or drop-ship kits to patients.
Receive Test Results
Plus, access Galaxy’s team for guidance when needed.
1 Center for Lyme Action analysis using percentages from prevalence and misdiagnosis studies Schwartz et al., 2017; Tibbles et al., 2007; Lipsker et al., 2004
2 Maggi RG, Calchi AC, Moore CO, Kingston E, Breitschwerdt EB. Human Babesia odocoilei and Bartonella spp. co-infections in the Americas. Parasit Vectors. 2024;17(1):302. doi:10.1186/s13071-024-06385-4
3 Babesiosis Disease Burden in United States is Substantially Higher Than Official Estimates, According to Preliminary Results of 60 Degrees Pharma Survey | 60 Degrees Pharmaceuticals, Inc.
